Lanthanum carbonate versus calcium carbonate: Effect on parathyroid hormone (PTH) levels.

被引：0
|
作者：
Hutchison, A
Webster, I
机构：
[1] Manchester Royal Infirm, Manchester Inst Nephrol & Transplantat, Manchester M13 9WL, Lancs, England
[2] Shire Pharmaceut Ltd, Basingstoke, Hants, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205A / 205A
页数：1
相关论文
共 50 条
  • [21] Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia:: A 6-month, randomized, comparative trial versus calcium carbonate
    Hutchison, AJ
    Maes, B
    Vanwalleghem, J
    Asmus, G
    Mohamed, E
    Schmieder, R
    Backs, W
    Jamar, R
    Vosskühler, A
    NEPHRON CLINICAL PRACTICE, 2005, 100 (01): : C8 - C19
  • [22] Effect of trace lanthanum ion on dissolution and crystal growth of calcium carbonate
    Kamiya, N
    Kagi, H
    Tsunomori, F
    Tsuno, H
    Notsu, K
    JOURNAL OF CRYSTAL GROWTH, 2004, 267 (3-4) : 635 - 645
  • [23] DIFFERENCES IN THE ACTIONS OF CALCIUM VERSUS LANTHANUM TO INFLUENCE PARATHYROID-HORMONE RELEASE
    FITZPATRICK, LA
    ENDOCRINOLOGY, 1990, 127 (02) : 711 - 715
  • [24] PARATHYROID-HORMONE (PTH) LEVELS IN HYPERCALCEMIA AND PARATHYROID DISEASE
    JIBRIL, AO
    MADERAORSINI, F
    VOLINI, FI
    CLINICAL CHEMISTRY, 1983, 29 (06) : 1254 - 1255
  • [25] Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats
    Ben-Dov, Iddo Z.
    Pappo, Orit
    Sklair-Levy, Miri
    Galitzer, Hillel
    Ilan, Yaron
    Naveh-Many, Tally
    Silver, Justin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (02) : 362 - 368
  • [26] INTERRELATIONSHIPS BETWEEN EXTRACELLULAR CALCIUM LEVELS AND PARATHYROID-HORMONE (PTH) SECRETION AND METABOLISM
    FISCHER, JA
    BLUM, JW
    DAMBACHER, MA
    HUNZIKER, W
    ACTA ENDOCRINOLOGICA, 1977, 85 : 22 - 22
  • [27] Is lanthanum carbonate safer and more effective than calcium carbonate for hyperphosphatemia in dialysis patients?
    Masafumi Fukagawa
    Nature Clinical Practice Nephrology, 2005, 1 : 20 - 21
  • [28] The effects of lanthanum carbonate (Fosrenol™) and calcium carbonate on renal bone disease in dialysis patients
    Haese, PCD
    Hutchinson, A
    Freemont, TJ
    De Broe, ME
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (04) : A17 - A17
  • [29] Effect of lanthanum carbonate versus calcium-based phosphate binders in dialysis patients: a meta-analysis
    Zhai, Chun-Juan
    Yu, Xin-Shuang
    Sun, Qiao-Ling
    Li, Lin
    Zhang, Li-Ting
    Zhou, Ai-Yan
    Wang, Rong
    CLINICAL NEPHROLOGY, 2014, 82 (06) : 372 - 378
  • [30] The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients
    Soriano, Sagrario
    Ojeda, Raquel
    Rodriguez, Mencarnacion
    Almaden, Yolanda
    Rodriguez, Mariano
    Martin-Malo, Alejandro
    Aljama, Pedro
    CLINICAL NEPHROLOGY, 2013, 80 (01) : 17 - 22
12345